Understanding how Bim affects blood vessel development in the retina under high oxygen conditions
Neural Retina-Specific Bim Expression and Hyperoxia Sensitivity of the Developing Retinal Vasculature
This study is looking at how a protein called Bim affects the growth of blood vessels in the eye, especially in situations where there's too much oxygen, which can be harmful for premature babies; by understanding this, researchers hope to find better ways to prevent or treat eye problems related to this condition.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Wisconsin-Madison NIH-funded |
| Lab location | 1 site (Madison, United States) |
| Project ID | NIH-10906285 on NIH RePORTER |
What this research studies
This research investigates the role of Bim, a protein involved in cell death, in the development of blood vessels in the retina, particularly under conditions of high oxygen, which can be harmful. The study uses a mouse model to explore how the absence of Bim protects retinal blood vessels from damage caused by hyperoxia, a condition often seen in premature infants. By examining the effects of Bim on retinal neurons and blood vessel formation, the research aims to uncover mechanisms that could lead to better treatments for eye diseases like retinopathy of prematurity. Patients may benefit from insights gained into how to prevent or treat vascular damage in the retina.
Who could benefit from this research
Good fit: Ideal candidates for this research are premature infants at risk for retinopathy of prematurity or those with similar retinal vascular issues.
Not a fit: Patients with established retinal damage or those not affected by conditions related to retinal vascular development may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new strategies for preventing vision loss in premature infants by targeting the mechanisms of retinal blood vessel development.
How similar studies have performed: Previous research has shown that targeting apoptotic pathways can be beneficial in similar contexts, suggesting a promising avenue for this investigation.
Where this research is happening
Madison, United States
- University of Wisconsin-Madison — Madison, United States (Active)
Researchers
- Principal investigator: Zaitoun, Ismail S — University of Wisconsin-Madison
- Study coordinator: Zaitoun, Ismail S
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.